Pelage Pharmaceuticals
CA - Los AngelesPharmaceutical
Focus: Pelage Pharmaceuticals is a Series B-stage biotech focused on hair follicle stimulation with applications in neurology, based in Los Angeles. The company remains pre-revenue with limited public disclosure on scale and market position.
Profile data last refreshed 22h ago · AI intelligence enriched 1w ago
Funding Stage
SERIES B
Total Funding
$14M
Open Jobs
0
About Pelage Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Pelage Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
PP405 0.05% Topical Gel
Androgenetic AlopeciaClinical Trials (1)
NCT06393452Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA
Phase 2Help build intelligence for Pelage Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.